Posted by Michael Wonder on 01 Jul 2021
WHO calls for lower prices on Gilead drug for COVID linked black fungus
1 July 2021 - The World Health Organization has called for prices of a Gilead Sciences drug to treat black fungus infections to be cut and supplies boosted amid a sharp rise in cases among Covid-19 patients in India and Nepal.
The California-based drugmaker produces AmBisome, a lipid-based amphotericin, which is used to treat the condition, also known as mucormycosis.
